Specialists in sleep medicine are attuned to the tip of the sleep apnea iceberg: The middle-aged overweight man with a thick neck and a partner describing snoring and pauses in his breathing. This is the slam-dunk patient who creates so much job satisfaction, with a clear diagnosis and often a […]
ARTICLES
Ozlo Raises $22 Million Series B Led by Modi Ventures to Expand Its Sleep Technology Ecosystem
Ozlo, the sleep technology company behind Ozlo Sleepbuds®, announced it has raised $22 million in Series B funding led by Modi Ventures. Existing investors LifeArc, Artis Ventures, ResMed, Scrum Ventures, Drive by DraftKings, Wheelhouse 360, Wise Ventures, Niremia Collective, Accelerate Ventures, and World Solver Syndicate participated, along with NFL Super […]
Resmed Launches AirTouch F40 Full Face Fabric CPAP Mask in the U.S.
Resmed announced the U.S. launch of AirTouch F40, the newest addition to its growing portfolio of fabric continuous positive airway pressure (CPAP) masks. Designed for people with obstructive sleep apnea (OSA) to provide greater comfort and choice in therapy1, the AirTouch F40 helps address key factors that can influence long-term […]
EnsoData Becomes First to Earn AASM Full Autoscoring Certification
EnsoData announced that EnsoSleep, its AI scoring software for in-lab and home sleep studies, is the first software to receive Full Autoscoring Certification from the American Academy of Sleep Medicine (AASM). The certification independently validates EnsoSleep’s performance across all four scoring domains evaluated by the program: sleep staging, respiratory events, […]
ProSomnus Announces Significant Scientific, Technical, and Advocacy Updates
ProSomnus Sleep Technologies announced the formation of its inaugural Medical Advisory Board, significant enhancements to its RPMO₂ platform, and growing clinical evidence supporting precision oral appliance therapy (OAT), including results from the FLOSAT study. These advancements will be highlighted during the company’s participation at CHEST 2026, October 19-21, 2026, in […]
Beacon Biosignals Acquires Snap Diagnostics, Paving the Way for EEG-Enabled Home Sleep Testing in Every Care Setting
Beacon Biosignals announced that it has acquired Snap Diagnostics, a premier home sleep testing (HST) provider serving patients in all 50 states. The acquisition more than doubles Beacon’s patient reach, making it one of the largest HST providers in the United States and establishing a national channel to bring EEG-enabled […]
Alkermes to Present Alixorexton and LUMRYZ Data at Sleep Europe 2026
Alkermes plc announced plans to present two oral presentations and six posters from its industry-leading portfolio of sleep medicine research at the European Sleep Research Society’s (ESRS) 28th Congress, Sleep Europe 2026, taking place Oct. 20-23, 2026 in Maastricht, the Netherlands. The company will present new data related to LUMRYZ® […]
Takeda’s ORZEYFUL Launches in Japan and China for Narcolepsy
Takeda announced that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the […]
Same CPAP, Different State: The Uneven Path to PAP Competency
My training for positive airway pressure (PAP) setup started with a few days of shadowing another employee at the durable medical equipment (DME) supplier where I worked. After that, I was handed a script to follow and a list of boxes to check during every setup. It covered how the […]
Carnyx Therapeutics Unveils CNYX-005 Oral Sleep Candidate
Carnyx Therapeutics Ltd. unveiled CNYX-005, its lead oral sleep candidate, alongside preclinical findings showing increased total sleep time and non-rapid eye movement (NREM) sleep in aged animal models. In the study, aged rats administered with CNYX-005 showed an approximately 1.5- to 2-hour increase in total sleep time compared to the control […]

















